{"id":"https://openalex.org/W2071069690","doi":"https://doi.org/10.7164/antibiotics.41.1253","title":"Biological activities of deoxyspergualin in autoimmune disease mice.","display_name":"Biological activities of deoxyspergualin in autoimmune disease mice.","publication_year":1988,"publication_date":"1988-01-01","ids":{"openalex":"https://openalex.org/W2071069690","doi":"https://doi.org/10.7164/antibiotics.41.1253","mag":"2071069690","pmid":"https://pubmed.ncbi.nlm.nih.gov/3263348"},"language":"en","primary_location":{"id":"doi:10.7164/antibiotics.41.1253","doi":"https://doi.org/10.7164/antibiotics.41.1253","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.41.1253","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/41/9/41_9_1253/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/41/9/41_9_1253/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110135434","display_name":"Kyuichi Nemoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KYUICHI NEMOTO","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan","Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd., Tokyo, Japan","institution_ids":["https://openalex.org/I4210150228"]},{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026457367","display_name":"Michiko Hayashi","orcid":"https://orcid.org/0000-0002-3666-7814","observed_orcids":["https://orcid.org/0000-0002-3666-7814"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"MICHIKO HAYASHI","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075251788","display_name":"Yumi Sugawara","orcid":"https://orcid.org/0000-0002-0197-6772","observed_orcids":["https://orcid.org/0000-0002-0197-6772"]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"YUMI SUGAWARA","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":null,"display_name":"JUNPEI ITO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"JUNPEI ITO","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108196353","display_name":"Fuminori Abe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"FUMINORI ABE","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110873290","display_name":"TOMOHISA TAKITA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150228","display_name":"Nippon Kayaku (Japan)","ror":"https://ror.org/05cbf4214","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210150228"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TOMOHISA TAKITA","raw_affiliation_strings":["Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Laboratories, Pharmaceuticals Group, Nippon Kayaku Co., Ltd","institution_ids":["https://openalex.org/I4210150228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016781421","display_name":"Teruya Nakamura","orcid":"https://orcid.org/0000-0003-2013-3057","observed_orcids":["https://orcid.org/0000-0003-2013-3057"]},"institutions":[{"id":"https://openalex.org/I4405273692","display_name":"Takara Shuzo Co., Ltd. (Japan)","ror":"https://ror.org/009xcqz70","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405273692"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TERUYA NAKAMURA","raw_affiliation_strings":["Central Research Laboratories, Takara Shuzo Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Takara Shuzo Co., Ltd","institution_ids":["https://openalex.org/I4405273692"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103855412","display_name":"TOMIO TAKEUCHI","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TOMIO TAKEUCHI","raw_affiliation_strings":["Institute of Microbial Chemistry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Microbial Chemistry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.909,"has_fulltext":true,"cited_by_count":22,"citation_normalized_percentile":{"value":0.85223297,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"41","issue":"9","first_page":"1253","last_page":"1259"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/deoxyspergualin","display_name":"deoxyspergualin","score":0.996999979019165},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.8650000095367432},{"id":"https://openalex.org/keywords/lupus-like-disease","display_name":"lupus-like syndrome","score":0.6349999904632568},{"id":"https://openalex.org/keywords/lupus-nephritis","display_name":"lupus nephritis","score":0.8169999718666077},{"id":"https://openalex.org/keywords/anti-dna-antibodies","display_name":"anti-DNA antibodies","score":0.8980000019073486},{"id":"https://openalex.org/keywords/lymphadenopathy","display_name":"lymphadenopathy","score":0.9800000190734863},{"id":"https://openalex.org/keywords/lipopolysaccharide-response","display_name":"lipopolysaccharide response","score":0.972000002861023},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.875},{"id":"https://openalex.org/keywords/interleukin-3","display_name":"interleukin-3","score":0.996999979019165},{"id":"https://openalex.org/keywords/spontaneous-autoimmunity","display_name":"spontaneous autoimmunity","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.7465701103210449},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6376457810401917},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.6304280757904053},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.4995861053466797},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48740676045417786},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.4776136577129364},{"id":"https://openalex.org/C2779075594","wikidata":"https://www.wikidata.org/wiki/Q8084905","display_name":"Autoimmune disease","level":3,"score":0.47618189454078674},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3568965792655945},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3341884911060333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3297600746154785},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2897951006889343},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.16539999842643738},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.15266811847686768}],"mesh":[{"descriptor_ui":"D000095602","descriptor_name":"Angucyclines and Angucyclinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D000880","descriptor_name":"Anthraquinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000974","descriptor_name":"Antibodies, Antinuclear","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001327","descriptor_name":"Autoimmune Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008181","descriptor_name":"Lupus Nephritis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008181","descriptor_name":"Lupus Nephritis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7164/antibiotics.41.1253","doi":"https://doi.org/10.7164/antibiotics.41.1253","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.41.1253","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/41/9/41_9_1253/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},{"id":"pmid:3263348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3263348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antibiotics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7164/antibiotics.41.1253","doi":"https://doi.org/10.7164/antibiotics.41.1253","is_oa":true,"landing_page_url":"https://doi.org/10.7164/antibiotics.41.1253","pdf_url":"https://www.jstage.jst.go.jp/article/antibiotics1968/41/9/41_9_1253/_pdf","source":{"id":"https://openalex.org/S154771817","display_name":"The Journal of Antibiotics","issn_l":"0021-8820","issn":["0021-8820","1881-1469"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Antibiotics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2071069690.pdf","grobid_xml":"https://content.openalex.org/works/W2071069690.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W197781038","https://openalex.org/W1506157243","https://openalex.org/W1514271462","https://openalex.org/W1891238929","https://openalex.org/W1968409702","https://openalex.org/W1999247918","https://openalex.org/W2005617526","https://openalex.org/W2037064071","https://openalex.org/W2056254152","https://openalex.org/W2069850534","https://openalex.org/W2074754820","https://openalex.org/W2081238619","https://openalex.org/W2124895467","https://openalex.org/W2142269895","https://openalex.org/W2146561639","https://openalex.org/W2398528730","https://openalex.org/W2411600073","https://openalex.org/W2417421122","https://openalex.org/W2431215556","https://openalex.org/W2431518693","https://openalex.org/W2443093592","https://openalex.org/W2465979516","https://openalex.org/W2473740934","https://openalex.org/W6814141026"],"related_works":["https://openalex.org/W1978462890","https://openalex.org/W2060614195","https://openalex.org/W2100017997","https://openalex.org/W2081505033","https://openalex.org/W2764480397","https://openalex.org/W2047866050","https://openalex.org/W1981962359","https://openalex.org/W2038476414","https://openalex.org/W2112278760","https://openalex.org/W2079224187"],"abstract_inverted_index":{"An":[0],"assessment":[1],"of":[2,8,36,82,113],"the":[3,34,70,111],"prophylactic":[4],"and":[5,50,89],"ameliorative":[6],"effects":[7],"deoxyspergualin":[9],"(NKT-01),":[10],"an":[11],"immunosuppressive":[12],"agent,":[13],"was":[14,29,61,77,95],"carried":[15],"out":[16],"in":[17,64,98,116],"male":[18],"MRL/MpJ-lpr/lpr":[19],"(MRL/1)":[20],"mice":[21,66,99],"which":[22],"spontaneously":[23],"develop":[24],"lupus-like":[25],"lesions.":[26],"When":[27],"NKT-01":[28,68,106],"administered":[30,67],"ip":[31],"daily":[32],"from":[33],"age":[35],"either":[37],"8":[38],"or":[39,92],"19":[40],"weeks,":[41],"diseases":[42],"such":[43],"as":[44],"massive":[45],"lymphadenopathy,":[46],"circulating":[47],"anti-DNA":[48],"antibody":[49],"lupus":[51],"nephritis":[52],"were":[53],"markedly":[54],"suppressed.":[55],"The":[56,80],"primary":[57],"response":[58,71],"to":[59,72,85],"lipopolysaccharide":[60],"significantly":[62,96],"reduced":[63],"MRL/1":[65,117],"but":[69],"sheep":[73],"red":[74],"blood":[75],"cells":[76,84],"not":[78],"affected.":[79],"ability":[81],"spleen":[83],"release":[86],"interleukins":[87],"2":[88],"3":[90],"with":[91],"without":[93],"mitogen":[94],"enhanced":[97],"receiving":[100],"NKT-01.":[101],"These":[102],"findings":[103],"demonstrate":[104],"that":[105],"has":[107],"therapeutic":[108],"activity":[109],"against":[110],"development":[112],"spontaneous":[114],"disease":[115],"mice.":[118]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}